364 related articles for article (PubMed ID: 26626481)
1. NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.
Shen C; Ipsaro JJ; Shi J; Milazzo JP; Wang E; Roe JS; Suzuki Y; Pappin DJ; Joshua-Tor L; Vakoc CR
Mol Cell; 2015 Dec; 60(6):847-59. PubMed ID: 26626481
[TBL] [Abstract][Full Text] [Related]
2. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.
Rahman S; Sowa ME; Ottinger M; Smith JA; Shi Y; Harper JW; Howley PM
Mol Cell Biol; 2011 Jul; 31(13):2641-52. PubMed ID: 21555454
[TBL] [Abstract][Full Text] [Related]
3. Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4.
Zhang Q; Zeng L; Shen C; Ju Y; Konuma T; Zhao C; Vakoc CR; Zhou MM
Structure; 2016 Jul; 24(7):1201-8. PubMed ID: 27291650
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8.
Yates JA; Menon T; Thompson BA; Bochar DA
FEBS Lett; 2010 Feb; 584(4):689-93. PubMed ID: 20085832
[TBL] [Abstract][Full Text] [Related]
5. Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair.
Zhao C; Dong C; Frah M; Deng Y; Marie C; Zhang F; Xu L; Ma Z; Dong X; Lin Y; Koenig S; Nait-Oumesmar B; Martin DM; Wu LN; Xin M; Zhou W; Parras C; Lu QR
Dev Cell; 2018 Jun; 45(6):753-768.e8. PubMed ID: 29920279
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of histone methyltransferase NSD3 on ISO-induced cardiac hypertrophy.
Chen K; Jian D; Zhao L; Zang X; Song W; Ma J; Jia Z; Wang X; Gao C
FEBS Lett; 2019 Sep; 593(18):2556-2565. PubMed ID: 31254363
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.
Crowe BL; Larue RC; Yuan C; Hess S; Kvaratskhelia M; Foster MP
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2086-91. PubMed ID: 26858406
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
[TBL] [Abstract][Full Text] [Related]
9. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.
Wu SY; Lee AY; Lai HT; Zhang H; Chiang CM
Mol Cell; 2013 Mar; 49(5):843-57. PubMed ID: 23317504
[TBL] [Abstract][Full Text] [Related]
10. Development of Murine Leukemia Virus Integrase-Derived Peptides That Bind Brd4 Extra-Terminal Domain as Candidates for Suppression of Acute Myeloid Leukemia.
Xing E; Surendranathan N; Kong X; Cyberski N; Garcia JD; Cheng X; Sharma A; Li PK; Larue RC
ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1628-1638. PubMed ID: 34661079
[TBL] [Abstract][Full Text] [Related]
11. BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia.
Sang X; Zhang Y; Fang F; Gao L; Tao Y; Li X; Zhang Z; Wang J; Tian Y; Li Z; Yao D; Wu Y; Chu X; Zhang K; Ma L; Lu L; Chen Y; Yu J; Zhuo R; Wu S; Zhang Z; Pan J; Hu S
J Immunol Res; 2022; 2022():7912484. PubMed ID: 35958877
[TBL] [Abstract][Full Text] [Related]
12. The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.
Conrad RJ; Fozouni P; Thomas S; Sy H; Zhang Q; Zhou MM; Ott M
Mol Cell; 2017 Sep; 67(6):1001-1012.e6. PubMed ID: 28844864
[TBL] [Abstract][Full Text] [Related]
13. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
[TBL] [Abstract][Full Text] [Related]
14. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.
Fiskus W; Sharma S; Qi J; Valenta JA; Schaub LJ; Shah B; Peth K; Portier BP; Rodriguez M; Devaraj SG; Zhan M; Sheng J; Iyer SP; Bradner JE; Bhalla KN
Mol Cancer Ther; 2014 May; 13(5):1142-54. PubMed ID: 24435446
[TBL] [Abstract][Full Text] [Related]
15. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
Zuber J; Shi J; Wang E; Rappaport AR; Herrmann H; Sison EA; Magoon D; Qi J; Blatt K; Wunderlich M; Taylor MJ; Johns C; Chicas A; Mulloy JC; Kogan SC; Brown P; Valent P; Bradner JE; Lowe SW; Vakoc CR
Nature; 2011 Aug; 478(7370):524-8. PubMed ID: 21814200
[TBL] [Abstract][Full Text] [Related]
16. BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.
Stewart HJ; Horne GA; Bastow S; Chevassut TJ
Cancer Med; 2013 Dec; 2(6):826-35. PubMed ID: 24403256
[TBL] [Abstract][Full Text] [Related]
17. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.
Wu SY; Chiang CM
J Biol Chem; 2007 May; 282(18):13141-5. PubMed ID: 17329240
[TBL] [Abstract][Full Text] [Related]
18. SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4.
Tzelepis K; De Braekeleer E; Aspris D; Barbieri I; Vijayabaskar MS; Liu WH; Gozdecka M; Metzakopian E; Toop HD; Dudek M; Robson SC; Hermida-Prado F; Yang YH; Babaei-Jadidi R; Garyfallos DA; Ponstingl H; Dias JML; Gallipoli P; Seiler M; Buonamici S; Vick B; Bannister AJ; Rad R; Prinjha RK; Marioni JC; Huntly B; Batson J; Morris JC; Pina C; Bradley A; Jeremias I; Bates DO; Yusa K; Kouzarides T; Vassiliou GS
Nat Commun; 2018 Dec; 9(1):5378. PubMed ID: 30568163
[TBL] [Abstract][Full Text] [Related]
19. Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure.
Wang R; Li Q; Helfer CM; Jiao J; You J
J Biol Chem; 2012 Mar; 287(14):10738-52. PubMed ID: 22334664
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition.
Rathert P; Roth M; Neumann T; Muerdter F; Roe JS; Muhar M; Deswal S; Cerny-Reiterer S; Peter B; Jude J; Hoffmann T; Boryń ŁM; Axelsson E; Schweifer N; Tontsch-Grunt U; Dow LE; Gianni D; Pearson M; Valent P; Stark A; Kraut N; Vakoc CR; Zuber J
Nature; 2015 Sep; 525(7570):543-547. PubMed ID: 26367798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
